Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. International Most cancers Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 international locations. CA Most cancers J Clin. 2021;71:209–49.
Klein CA. Most cancers development and the invisible section of metastatic colonization. Nat Rev Most cancers. 2020;20:681–94.
Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Most cancers. 2009;9:274–84.
Sleeman JP. The lymph node pre-metastatic area of interest. J Mol Med (Berl). 2015;93:1173–84.
Fish ML, Grover R, Schwarz GS. High quality-of-life outcomes in Surgical vs Nonsurgical therapy of breast Most cancers-related Lymphedema: a scientific overview. JAMA Surg. 2020;155:513–9.
Rossi, EJBaijoo. gynaecology: An evolution in sentinel node mapping for cervical most cancers. 2020.
Zalewski Okay, Benke M, Mirocha B, Radziszewski J, Chechlinska M, Kowalewska M. Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: gynecologic oncology perspective. Curr Pharm Des. 2018;24:1652–75.
Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in most cancers of the parotid. Most cancers. 1960;13:77–8.
Amersi F, Hansen NM. The advantages and limitations of sentinel lymph node biopsy. Curr Deal with Choices Oncol. 2006;7:141–51.
Stadelmann WK. The position of lymphatic mapping and sentinel lymph node biopsy within the staging and therapy of melanoma. Clin Plast Surg. 2010;37:79–99.
Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL. New approaches to lymphatic imaging. Lymphat Res Biol. 2009;7:205–14.
Cousins A, Tsopelas C, Balalis G, Thompson SK, Bartholomeusz D, Wedding ceremony AB, Thierry B. Hybrid (99m)Tc-magnetite tracer for twin modality sentinel lymph node mapping. J Mater Sci Mater Med. 2018;29:76.
Pelosi E, Area V, Baudino B, Bellò M, Giusti M, Gargiulo T, Palladin D, Bisi G. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial most cancers. Nucl Med Commun. 2003;24:971–5.
Mohammad A, Hunter MI. Robotic-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection utilizing Close to-infrared fluorescence in Vulvar Most cancers. J Minim Invasive Gynecol. 2019;26:968–72.
Zakaria S, Hoskin TL, Degnim AC. Security and technical success of methylene blue dye for lymphatic mapping in breast most cancers. Am J Surg. 2008;196:228–33.
Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, Russell SE. Efficient low-dose escalation of Indocyanine Inexperienced for Close to-infrared fluorescent Sentinel Lymph Node Mapping in Melanoma. Ann Surg Oncol. 2013;20:2357–63.
Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, Dor DM, Cohn LH, Bawendi MG, Frangioni JV, Mihaljevic T. Intraoperative Sentinel Lymph Node Mapping of the lung utilizing Close to-Infrared fluorescent Quantum dots. Ann Thorac Surg. 2005;79:269–77.
He M, Jiang Z, Wang C, Hao Z, An J, Shen J. Diagnostic worth of near-infrared or fluorescent indocyanine inexperienced guided sentinel lymph node mapping in gastric most cancers: a scientific overview and meta-analysis. J Surg Oncol. 2018;118:1243–56.
Zulfajri M, Abdelhamid HN, Sudewi S, Dayalan S, Rasool A, Habib A, Huang GG. Plant Half-Derived Carbon Dots for Biosensing.Biosensors (Basel)2020,10.
Wang W, Hu Z. Concentrating on peptide-based probes for molecular imaging and analysis. Adv Mater. 2019;31:e1804827.
Tajima Y, Yamazaki Okay, Masuda Y, Kato M, Yasuda D, Aoki T, Kato T, Murakami M, Miwa M, Kusano M. Sentinel node mapping guided by indocyanine inexperienced fluorescence imaging in gastric most cancers. Ann Surg. 2009;249:58–62.
Ankersmit M, Bonjer HJ, Hannink G, Schoonmade LJ, van der Pas M, Meijerink W. Close to-infrared fluorescence imaging for sentinel lymph node identification in colon most cancers: a potential single-center research and systematic overview with meta-analysis. Tech Coloproctol. 2019;23:1113–26.
Hachey KJ, Digesu CS, Armstrong KW, Gilmore DM, Khullar OV, Whang B, Tsukada H, Colson YL. A novel approach for tumor localization and focused lymphatic mapping in early-stage lung most cancers. J Thorac Cardiovasc Surg. 2017;154:1110–8.
Noh YW, Park HS, Sung MH, Lim YT. Enhancement of the photostability and retention time of indocyanine inexperienced in sentinel lymph node mapping by anionic polyelectrolytes. Biomaterials. 2011;32:6551–7.
Lee S, Xie J, Chen X. Peptide-based probes for focused molecular imaging. Biochemistry. 2010;49:1364–76.
Shan L. Activatable Alexa Fluor680-conjugated panitumumab and indocyanine green-conjugated trastuzumab cocktail. Molecular Imaging and Distinction Agent Database (MICAD). Bethesda (MD):Nationwide Heart for Biotechnology Data (US); 2004
Olafsen T, Wu AM. Antibody vectors for imaging. Semin Nucl Med. 2010;40:167–81.
Yeh CY, Hsiao JK, Wang YP, Lan CH, Wu HC. Peptide-conjugated nanoparticles for focused imaging and remedy of prostate most cancers. Biomaterials. 2016;99:1–15.
Katsamakas S, Chatzisideri T, Thysiadis S, Sarli V. RGD-mediated supply of small-molecule medication. Future Med Chem. 2017;9:579–604.
Yang W, Luo D, Wang S, Wang R, Chen R, Liu Y, Zhu T, Ma X, Liu R, Xu G, et al. TMTP1, a novel tumor-homing peptide particularly focusing on metastasis. Clin Most cancers Res. 2008;14:5494–502.
Wei R, Jiang G, Lv M, Tan S, Wang X, Zhou Y, Cheng T, Gao X, Chen X, Wang W, et al. TMTP1-modified Indocyanine Inexperienced-loaded polymeric micelles for focused imaging of Cervical Most cancers and Metastasis Sentinel Lymph Node in vivo. Theranostics. 2019;9:7325–44.
Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, et al. Analysis of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent focusing on metastasis with SPECT. Nucl Med Biol. 2015;42:256–62.
Liu R, Ma X, Wang H, Xi Y, Qian M, Yang W, Luo D, Fan L, Xia X, Zhou J, et al. The novel fusion protein sTRAIL-TMTP1 reveals a focused inhibition of major tumors and metastases. J Mol Med (Berl). 2014;92:165–75.
Liu R, Xi L, Luo D, Ma X, Yang W, Xi Y, Wang H, Qian M, Fan L, Xia X, et al. Enhanced focused anticancer results and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD. J Management Launch. 2012;161:893–902.
Wang L, Zhang D, Li J, Li F, Wei R, Jiang G, Xu H, Wang X, Zhou Y, Xi L. A novel ICG-labeled cyclic TMTP1 peptide dimer for delicate tumor imaging and enhanced photothermal remedy in vivo. Eur J Med Chem. 2022;227:113935.
Zhou Y, Jiang G, Wang W, Wei R, Chen X, Wang X, Wei J, Ma D, Li F, Xi L. A Novel Close to-Infrared fluorescent probe TMTP1-PEG4-ICG for in vivo Tumor Imaging. Bioconjug Chem. 2018;29:4119–26.
Li F, Zhang Z, Cai J, Chen X, Zhou Y, Ma X, Dong Q, Li F, Xi L. Major preclinical and scientific analysis of (68)Ga-DOTA-TMVP1 as a novel VEGFR-3 PET imaging Radiotracer in Gynecological Most cancers. Clin Most cancers Res. 2020;26:1318–26.
Iraji M, Salehi M, Malekshah RE, Khaleghian A, Shamsi F. Liposomal formulation of latest arsenic schiff base advanced as drug supply agent within the therapy of acute promyelocytic leukemia and quantum chemical and docking calculations. J Drug Deliv Sci Technol. 2022;75:103600.
Abdelhamid HN. Zeolitic Imidazolate Frameworks (ZIF-8) for Biomedical Purposes: a overview. Curr Med Chem. 2021;28:7023–75.
Moharramnejad M, Ehsani A, Shahi M, Gharanli S, Saremi H, Malekshah RE, Basmenj ZS, Salmani S, Mohammadi M. MOF as nanoscale drug supply units: synthesis and up to date progress in biomedical purposes. J Drug Deliv Sci Technol. 2023;81:104285.
Solar Q, Zhou Z, Qiu N, Shen Y. Rational Design of Most cancers Nanomedicine: Nanoproperty Integration and Synchronization.Adv Mater2017,29.
Gholivand Okay, Mohammadpour M, Alavinasab Ardebili SA, Eshaghi Malekshah R, Samadian H. Fabrication and examination of polyorganophosphazene/polycaprolactone-based scaffold with degradation, in vitro and in vivo behaviors appropriate for tissue engineering purposes. Sci Rep. 2022;12:18407.
Noh YW, Kong SH, Choi DY, Park HS, Yang HK, Lee HJ, Kim HC, Kang KW, Sung MH, Lim YT. Close to-infrared emitting polymer nanogels for environment friendly sentinel lymph node mapping. ACS Nano. 2012;6:7820–31.
Luo S, Zhang E, Su Y, Cheng T, Shi C. A overview of NIR dyes in most cancers focusing on and imaging. Biomaterials. 2011;32:7127–38.
Dai J, Rabie AB. VEGF: a vital mediator of each angiogenesis and endochondral ossification. J Dent Res. 2007;86:937–50.
Sallinen H, Anttila M, Grohn O, Koponen J, Hamalainen Okay, Kholova I, Kosma VM, Heinonen S, Alitalo Okay, Yla-Herttuala S. Cotargeting of VEGFR-1 and – 3 and angiopoietin receptor Tie2 reduces the expansion of strong human ovarian most cancers in mice. Most cancers Gene Ther. 2011;18:100–9.
Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio Okay, Tamura T, Koizumi F. Sunitinib inhibits lymphatic endothelial cell features and lymph node metastasis in a breast most cancers mannequin by way of inhibition of vascular endothelial development issue receptor 3. Breast Most cancers Res. 2011;13:R66.
García-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada AR, Medina MA, Noël A. Concentrating on VEGFR-3/-2 signaling pathways with AD0157: a possible technique towards tumor-associated lymphangiogenesis and lymphatic metastases.Journal of Hematology & Oncology2017,10.
Gu P, Wusiman A, Wang S, Zhang Y, Liu Z, Hu Y, Liu J, Wang D. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to boost immune responses. Carbohydr Polym. 2019;223:115128.
Proulx ST, Luciani P, Derzsi S, Rinderknecht M, Mumprecht V, Leroux JC, Detmar M. Quantitative imaging of lymphatic operate with liposomal indocyanine inexperienced. Most cancers Res. 2010;70:7053–62.
Zheng X, Zhou F, Wu B, Chen WR, Xing D. Enhanced tumor therapy utilizing biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection. Mol Pharm. 2012;9:514–22.
Kraft JC, Ho RJ. Interactions of indocyanine inexperienced and lipid in enhancing near-infrared fluorescence properties: the premise for near-infrared imaging in vivo. Biochemistry. 2014;53:1275–83.
MacDonald RI. Traits of self-quenching of the fluorescence of lipid-conjugated rhodamine in membranes. J Biol Chem. 1990;265:13533–9.
Yoon HK, Ray A, Lee YE, Kim G, Wang X, Kopelman R. Polymer-Protein Hydrogel Nanomatrix for Stabilization of Indocyanine Inexperienced in the direction of Focused Fluorescence and Photoacoustic Bio-imaging.J Mater Chem B2013,1.
Hill TK, Abdulahad A, Kelkar SS, Marini FC, Lengthy TE, Provenzale JM, Mohs AM. Indocyanine green-loaded nanoparticles for image-guided tumor surgical procedure. Bioconjug Chem. 2015;26:294–303.
Fu X, Fu S, Cai Z, Jin R, Xia C, Lui S, Track B, Gong Q, Ai H. Manganese porphyrin/ICG nanoparticles as magnetic resonance/fluorescent dual-mode probes for imaging of sentinel lymph node metastasis. J Mater Chem B. 2022;10:10065–74.
Steeg PS. Concentrating on metastasis. Nat Rev Most cancers. 2016;16:201–18.
Talmadge JE, Fidler IJ. AACR centennial sequence: the biology of most cancers metastasis: historic perspective. Most cancers Res. 2010;70:5649–69.
Schulze T, Bembenek A, Schlag PM. Sentinel lymph node biopsy progress in surgical therapy of most cancers. Langenbecks Arch Surg. 2004;389:532–50.
Falk Delgado A, Zommorodi S, Falk Delgado A. Sentinel Lymph Node Biopsy and Full Lymph Node Dissection for Melanoma. Curr Oncol Rep. 2019;21:54.
Ulmer A, Kofler L. [Sentinel node biopsy and lymph node dissection in the era of new systemic therapies for malignant melanoma]. Hautarzt. 2019;70:864–9.
Göppner D, Nekwasil S, Jellestad A, Sachse A, Schönborn KH, Gollnick H. Indocyanine green-assisted sentinel lymph node biopsy in melanoma utilizing the “FOVIS” system. J Dtsch Dermatol Ges. 2017;15:169–78.
Verbeek FP, Tummers QR, Rietbergen DD, Peters AA, Schaafsma BE, van de Velde CJ, Frangioni JV, van Leeuwen FW, Gaarenstroom KN, Vahrmeijer AL. Sentinel Lymph Node Biopsy in Vulvar Most cancers utilizing mixed Radioactive and fluorescence Steerage. Int J Gynecol Most cancers. 2015;25:1086–93.
Guo J, Yang H, Wang S, Cao Y, Liu M, Xie F, Liu P, Zhou B, Tong F, Cheng L, et al. Comparability of sentinel lymph node biopsy guided by indocyanine inexperienced, blue dye, and their mixture in breast most cancers sufferers: a potential cohort research. World J Surg Oncol. 2017;15:196.
Helle M, Rampazzo E, Monchanin M, Marchal F, Guillemin F, Bonacchi S, Salis F, Prodi L, Bezdetnaya L. Floor chemistry structure of silica nanoparticles decide the effectivity of in vivo fluorescence lymph node mapping. ACS Nano. 2013;7:8645–57.
Arif U, Haider S, Haider A, Khan N, Alghyamah AA, Jamila N, Khan MI, Almasry WA, Kang IK. Biocompatible polymers and their potential Biomedical Purposes: a overview. Curr Pharm Des. 2019;25:3608–19.
Mir M, Ahmed N, Rehman AU. Current purposes of PLGA based mostly nanostructures in drug supply. Colloids Surf B Biointerfaces. 2017;159:217–31.
Fornaguera C, Feiner-Gracia N, Calderó G, García-Celma MJ, Solans C. PLGA nanoparticles from nano-emulsion templating as imaging brokers: versatile know-how to acquire nanoparticles loaded with fluorescent dyes. Colloids Surf B Biointerfaces. 2016;147:201–9.
Zhang Okay, Tang X, Zhang J, Lu W, Lin X, Zhang Y, Tian B, Yang H, He H. PEG-PLGA copolymers: their construction and structure-influenced drug supply purposes. J Management Launch. 2014;183:77–86.
Lin WJ, Lee WC. Polysaccharide-modified nanoparticles with clever CD44 receptor focusing on capacity for gene supply. Int J Nanomedicine. 2018;13:3989–4002.
Zhou H, Fan Z, Deng J, Lemons PK, Arhontoulis DC, Bowne WB, Cheng H. Hyaluronidase embedded in Nanocarrier PEG Shell for enhanced tumor penetration and extremely environment friendly Antitumor Efficacy. Nano Lett. 2016;16:3268–77.
Mumprecht V, Detmar M. Lymphangiogenesis and most cancers metastasis. J Cell Mol Med. 2009;13:1405–16.
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo Okay. Expression of the fms-like tyrosine kinase 4 gene turns into restricted to lymphatic endothelium throughout growth. Proc Natl Acad Sci U S A. 1995;92:3566–70.
Kaipainen A, Korhonen J, Mustonen T, Hinsbergh VWMV, Fang GH, Dumont D, Breitman M, Alitalo KJPotNAoS: Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Beitman M, Alitalo. Okay.Expression of the fms-like tyrosine kinase 4 gene turns into restricted to lymphatic endothelium throughout growth. Proc Natl Acad Sci USA. 1995;92:3566–70.
Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud Okay, Tonra JR, Witte L, Alitalo Okay. Vascular endothelial development issue receptor 3 is concerned in tumor angiogenesis and development. Most cancers Res. 2007;67:593–9.
Balsat C, Blacher S, Herfs M, Van de Velde M, Signolle N, Sauthier P, Pottier C, Gofflot S, De Cuypere M, Delvenne P, et al. A particular immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in sufferers with early cervical most cancers. Oncoimmunology. 2017;6:e1265718.
Smith NR, Baker D, James NH, Ratcliffe Okay, Jenkins M, Ashton SE, Sproat G, Swann R, Grey N, Ryan A, et al. Vascular endothelial development issue receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human major strong cancers. Clin Most cancers Res. 2010;16:3548–61.
Hameed S, Chen H, Irfan M, Bajwa SZ, Khan WS, Baig SM, Dai Z. Fluorescence guided Sentinel Lymph Node Mapping: from present Molecular Probes to Future Multimodal Nanoprobes. Bioconjug Chem. 2019;30:13–28.
Chen J, Chen L, Zeng F, Wu S. Aminopeptidase N activatable nanoprobe for monitoring lymphatic metastasis and guiding tumor resection surgical procedure by way of Optoacoustic/NIR-II fluorescence Twin-Mode Imaging. Anal Chem. 2022;94:8449–57.
Hou X, Tao Y, Pang Y, Li X, Jiang G, Liu Y. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor therapy. Int J Most cancers. 2018;143:3050–60.
Doroshow JH, Simon RM. On the design of Mixture Most cancers Remedy. Cell. 2017;171:1476–8.
Li J, Zhuang Z, Jiang B, Zhao P, Lin C. Advances and views in nanoprobes for noninvasive lymph node mapping. Nanomed (Lond). 2015;10:1019–36.
Cai X, Liu X, Liao LD, Bandla A, Ling JM, Liu YH, Thakor N, Bazan GC, Liu B. Encapsulated conjugated oligomer nanoparticles for real-time photoacoustic Sentinel Lymph Node Imaging and focused photothermal remedy. Small. 2016;12:4873–80.
Feng HY, Yuan Y, Zhang Y, Liu HJ, Dong X, Yang SC, Liu XL, Lai X, Zhu MH, Wang J, et al. Focused Micellar Phthalocyanine for Lymph Node Metastasis Homing and Photothermal Remedy in an Orthotopic Colorectal Tumor Mannequin. Nanomicro Lett. 2021;13:145.
Shi H, Yan R, Wu L, Solar Y, Liu S, Zhou Z, He J, Ye D. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal remedy of lymph node metastasis. Acta Biomater. 2018;72:256–65.
Ji C, Zhao M, Wang C, Liu R, Zhu S, Dong X, Su C, Gu Z. Biocompatible Tantalum Nanoparticles as Radiosensitizers for enhancing remedy efficacy in major tumor and metastatic Sentinel Lymph Nodes. ACS Nano. 2022;16:9428–41.
Ma R, Tang X, Wang M, Du Z, Chen S, Heng Y, Zhu L, Alifu N, Zhang X, Ma C. Scientific indocyanine green-based silk fibroin theranostic nanoprobes for in vivo NIR-I/II fluorescence imaging of cervical illnesses. Nanomedicine. 2023;47:102615.
Yang Z, Tian R, Wu J, Fan Q, Yung BC, Niu G, Jacobson O, Wang Z, Liu G, Yu G, et al. Impression of Semiconducting Perylene Diimide nanoparticle dimension on Lymph Node Mapping and Most cancers Imaging. ACS Nano. 2017;11:4247–55.
Cao Y, Track W, Jiang Q, Xu Y, Cai S, Wang S, Yang W. Nanoparticles from historical ink endowing a Inexperienced and Efficient Technique for Most cancers Photothermal Remedy within the Second Close to-Infrared window. ACS Omega. 2020;5:6177–86.
Dai R, Peng X, Lin B, Xu D, Lv R. NIR II luminescence imaging for Sentinel Lymph Node and enhanced Chemo-/Photothermal remedy for breast Most cancers. Bioconjug Chem. 2021;32:2117–27.
Yang L, Cheng J, Chen Y, Yu S, Liu F, Solar Y, Chen Y, Ran H. Section-transition nanodroplets for real-time Photoacoustic/Ultrasound Twin-Modality Imaging and Photothermal Remedy of Sentinel Lymph Node in breast Most cancers. Sci Rep. 2017;7:45213.
Ali MRK, Warner PE, Yu AM, Tong M, Han T, Tang Y. Stopping metastasis utilizing gold nanorod-assisted Plasmonic Photothermal Remedy in Xenograft mice. Bioconjug Chem. 2022;33:2320–31.
Jiang G, Wang X, Zhou Y, Zou C, Wang L, Wang W, Zhang D, Xu H, Li J, Li F, et al. TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Ship Cisplatin and Paclitaxel Prodrugs for Efficient Cervical Most cancers Remedy. Int J Nanomedicine. 2021;16:4087–104.
Ishima Y, Yamazaki N, Chuang VTG, Shimizu T, Ando H, Ishida T. A maleimide-terminally modified PEGylated Liposome Induced the Accelerated Blood Clearance Impartial of the manufacturing of Anti-PEG IgM antibodies. Biol Pharm Bull. 2022;45:1518–24.
